Research To Practice | Oncology Videos

Featuring an interview with Dr Christopher L Moertel, including the following topics: CME information and select publications

Featuring a slide presentation and related discussion from Dr Christopher L Moertel, including the following topics: CME information and select publications

Featuring an interview with Dr Sara A Hurvitz, including the following topics: CME information and select publications

Featuring an interview with Dr Tiffany A Richards, including the following topics: (0:00) NCPD information and select publications

Featuring an interview with Dr Komal Jhaveri, including the following topics: Nat Rev Clin Oncol Abstract CME information and select publications

Featuring an interview with Ms Robin Klebig, including the following topics: (0:00) NCPD information and select publications

Featuring perspectives from Dr Thomas E Hutson, Dr Rana R McKay, Dr Sumanta Kumar Pal and Dr Tian Zhang, moderated by Dr Pal, including the following topics: Introduction CME information and select publications

Featuring perspectives from Dr Scott Kopetz and Dr Jeffrey Meyerhardt, including the following topics: CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 2: Advances in the Management of Metastatic CRC (mCRC) — Scott Kopetz, MD, PhD CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 1: Optimizing the Care of Patients with Localized Colorectal Cancer (CRC) — Jeffrey Meyerhardt, MD, MPH CME information and select publications

Featuring perspectives from Dr Kevin S Hughes and Dr Mark Robson, including the following topics: Introduction CME information and select publications

Featuring perspectives from Dr Terence Friedlander and Dr Matthew D Galsky, Dr Neeraj Agarwal and Dr Andrew J Armstrong, moderated by Dr Elisabeth I Heath, including the following topics: Introduction CME information and select publications

Featuring an interview with Dr Komal Jhaveri, including the following topics: Abstract GS1-01N Engl J Med AbstractClin Cancer Res AbstractNat Rev Clin Oncol Abstract CME information and select publications

Featuring perspectives from Prof John Bridgewater, including the following topics: Introduction: Biology and Epidemiology; Classification CME information and select publications

Featuring slide presentations and related discussion from Prof Martin Hutchings, Dr Manali Kamdar, Dr Matthew Lunning and Prof Gilles Salles, including the following topics: CME information and select publications

Featuring perspectives from Dr Arvind Dasari, Dr Christopher Lieu, Dr Van K Morris, Dr Jenny Seligmann and Prof Eric Van Cutsem, moderated by Dr Lieu, including the following topics: Introduction CME information and select publications

Featuring an interview with Dr Surbhi Sidana, including the following topics: (0:00) CME information and select publications

Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics: (0:00) CME information and select publications

Featuring slide presentations and related discussion from Dr Joyce O'Shaughnessy, Dr Mark Pegram and Prof Peter Schmid, including the following topics: Strategies to Identify Patients with HER2-Low and HER2-Ultralow Breast Cancer(0:00)Case: A woman in her mid 50s initially presenting with ER-positive, HER2 IHC 1+ locally advanced breast cancer who experiences progression to HER2 0 metastatic disease (20:53)Case: A woman in her early 60s with ER-positive, HER2 IHC 1+ metastatic breast cancer (mBC) who experiences disease progression 8 months after starting first-line CDK4/6 and aromatase inhibitor (29:14)Expanding the Spectrum of Targeted Therapy (38:52)Case: A woman in her early 60s with HR-positive, HER2 IHC 1+ mBC who receives fifth-line T-DXd resulting in stable disease (1:04:13)Case: A woman in her early 50s with progressive HR-positive, HER2 IHC 0 mBC and an ESR1 mutation who has ultralow HER2 expression on rebiopsy of new liver lesions (1:12:35)Identification and Management of Adverse Events with T-DXd (1:20:27)Case: A woman in her late 40s with HR-positive, HER2 IHC 2+ mBC who experienced persistent low-grade nausea with T-DXd that resolved with olanzapine (1:34:02)Case: A woman in her early 60s with ER-positive, HER2 2+ mBC who received T-DXd resulting in fatigue and asymptomatic interstitial lung disease CME information and select publications

Featuring perspectives from Dr Anthony El-Khoueiry, Dr Richard S Finn, Dr Aiwu Ruth He and Dr Stacey Stein, moderated by Dr Stephen “Fred” Divers, including the following topics: CME information and select publications